A NEW TORIC IOL MARKER FOR INTRA-OPERATIVE ALIGNMENT OF TORIC IOLS IN SMALL PUPILS DURING PHACOEMULSIFICATIO

Not Applicable

Completed

• Conditions: Health Condition 1: H00-H59- Diseases of the eye and adnexa

• Registration Number: CTRI/2019/12/022583
• Lead Sponsor: ETHRADHAMA SUPER SPECIALTY EYE HOSPITA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2020-12-30
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

1.Patients having small pupil (Less than 7mm)- PXF/ diabetic patients with mid dilating pupil/Non- dilating pupil with cataract for which phacoemulsification or femtolaser assisted cataract surgery with posterior chamber Toric IOL implantation

2.Post Femtolaser related miosis with cataract

3.Patients who fail to dilate on the day of surgery even though Pre-Op assessment showed well dilating pupil

4.Male or female in good general health, 40-80 years of age at the time of the pre-operative examination

5.A patient has the visual potential of 20/25 or better in each eye after cataract removal and IOL implantation

6.A patient with preoperative corneal astigmatism more than 1D and stable corneal conditions within the last 12 months

7.A patient with clear ocular media other than cataract in each eye

8.A patient with normal OCT of the macula in each eye

Exclusion Criteria

1.Patients having fully dilated pupil on table (Femto/ Non- Femto cases)

2.A patient with a known pathology that may affect visual acuity (as determined by the Investigator); particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.) in either eye

3.A patient with amblyopia or strabismus

4.A patient with capsule or zonular abnormalities that may affect postoperative centration or tilt of the lens (e.g. pseudoexfoliation syndrome) in either eye

5.A patient has a history of significant ocular trauma or prior ocular surgery in either eye

6.A patient with cornea guttata, corneal scarring, keratoplasty, irregular astigmatism (e.g. Keratoconus)

7.A patient that may or is expected to undergo surgical intervention and/or ocular laser treatment prior to or during the study period in either eye

8.Need for a dioptre out of the range of +16.0D to +26.0D

9.A patient with any uncontrolled systemic disease. A potential patient in whom therapy for a systemic disease is not yet stabilized will not be considered for entry into the study

10.A patient currently participating or has participated within 30 days prior to the start of this study in a drug or other investigational research study

Study & Design

• Study Type: Interventional
• Study Design: Not specified